Samlyn Capital: $668 Million in Quarterly Healthcare Stock Positions

Wall St. Watchdog reveals information regarding Samlyn Capital Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 25 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $668.626 million.

  • Boston Scientific Corporation (NYSE:BSX): On 06/30/2011, Samlyn Capital Management reported holding 8,814,400 shares with a market value of $60,907,503. This comprised 1.96% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 15,282,400 shares with a market value of $90,318,982. This comprised 3.64% of the total portfolio. The net change in shares for this position over the two quarters is 6,468,000. About Company: Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Samlyn Capital Management reported holding 1,935,500 shares with a market value of $39,871,301. This comprised 1.29% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 4,989,043 shares with a market value of $88,206,282. This comprised 3.56% of the total portfolio. The net change in shares for this position over the two quarters is 3,053,543. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Samlyn Capital Management reported holding 0 shares. On 09/30/2011, Samlyn Capital Management reported holding 981,900 shares with a market value of $64,098,431. This comprised 2.59% of the total portfolio. The net change in shares for this position over the two quarters is 981,900. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP): On 06/30/2011, Samlyn Capital Management reported holding 1,037,400 shares with a market value of $41,672,356. This comprised 1.34% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 2,000,000 shares with a market value of $55,980,000. This comprised 2.26% of the total portfolio. The net change in shares for this position over the two quarters is 962,600. About Company: Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo’s products include Percocet, Percodan, and Lidoderm.
  • Aetna Inc. (NYSE:AET): On 06/30/2011, Samlyn Capital Management reported holding 1,498,192 shares with a market value of $66,055,286. This comprised 2.13% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 1,386,492 shares with a market value of $50,385,119. This comprised 2.03% of the total portfolio. The net change in shares for this position over the two quarters is -111,700. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Covidien Plc (NYSE:COV): On 06/30/2011, Samlyn Capital Management reported holding 905,800 shares with a market value of $48,215,734. This comprised 1.55% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 1,100,000 shares with a market value of $48,509,998. This comprised 1.96% of the total portfolio. The net change in shares for this position over the two quarters is 194,200. About Company: Covidien PLC is a global healthcare products company. The Company develops, manufactures and distributes a diverse range of medical devices and supplies, diagnostics imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.
  • Cigna Corporation (NYSE:CI): On 06/30/2011, Samlyn Capital Management reported holding 1,239,166 shares with a market value of $63,730,308. This comprised 2.05% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 1,005,566 shares with a market value of $42,173,437. This comprised 1.7% of the total portfolio. The net change in shares for this position over the two quarters is -233,600. About Company: CIGNA Corporation, through its subsidiaries, provides group life and health insurance, managed care products and services, retirement products and services, and individual financial services worldwide. The Company also sells individual life and health insurance and annuity products in selected international locations.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Samlyn Capital Management reported holding 977,600 shares with a market value of $47,139,873. This comprised 1.52% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 802,100 shares with a market value of $29,854,163. This comprised 1.2% of the total portfolio. The net change in shares for this position over the two quarters is -175,500. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Hospira Inc. (NYSE:HSP): On 06/30/2011, Samlyn Capital Management reported holding 810,000 shares with a market value of $45,894,600. This comprised 1.48% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 705,400 shares with a market value of $26,099,800. This comprised 1.05% of the total portfolio. The net change in shares for this position over the two quarters is -104,600. About Company: Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Samlyn Capital Management reported holding 588,630 shares with a market value of $30,361,536. This comprised 0.98% of the total portfolio. On 09/30/2011, Samlyn Capital Management reported holding 431,800 shares with a market value of $19,914,616. This comprised 0.8% of the total portfolio. The net change in shares for this position over the two quarters is -156,830. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.

(Note: Data regarding Samlyn Capital Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet